Report

Vietnam Life Science Tools market size was valued at USD 1.62 billion in 2022 and is expected to reach USD 3.26 billion in 2030 with a CAGR of 9.12% for the forecast period between 2023 and 2030. The Vietnam life science tools market has experienced significant growth and development in recent years.
Increasing prevalence of chronic diseases, growing awareness & adoption of precision medicine, increasing government support and growing healthcare expenditure are some of the factors that are driving the life sciences tools market in Vietnam. The country's growing population and the prevalence of diseases such as cancer, diabetes, and infectious diseases have necessitated the need for efficient and accurate diagnostic tools, driving market expansion. The emergence of biotechnology and pharmaceutical companies in Vietnam has further contributed to the demand for life science tools. These companies require a wide range of tools, including molecular biology kits, sequencing platforms, cell culture systems, and chromatography instruments, to support their research and development efforts.
The government's focus on promoting research and development activities has spurred the demand for life science tools. Initiatives aimed at enhancing the country's scientific infrastructure, fostering collaborations between academia and industry, and attracting foreign investment have created a conducive environment for the growth of the life science sector.
Rapid Rise and Proliferation of PCR Technology
Polymerase chain reaction (PCR) technology is witnessing a remarkable surge in advancement and utilization. PCR, a powerful molecular biology technique used to amplify DNA sequences, has gained significant traction in various fields, including diagnostics, research, forensics, and agriculture. The increasing adoption of PCR can be attributed to several factors. Firstly, the growing awareness among healthcare professionals, researchers, and policymakers about the benefits of PCR has fueled its widespread use. PCR enables rapid and accurate detection of pathogens, identification of genetic variations, and diagnosis of genetic disorders, contributing to improved patient care and disease management. The availability of advanced PCR instruments and reagents has played a crucial role in driving its uptake. Leading life science companies have introduced innovative PCR platforms that offer enhanced sensitivity, specificity, and multiplexing capabilities. These advancements have made PCR more accessible and user-friendly, allowing researchers and clinicians in Vietnam to perform complex molecular analyses with ease.
In July 2022, Seegene launched the world's first In-life PCR campaign in Vietnam with the aim of promoting frequent testing of respiratory viruses on a global scale. Seegene supplied LabHouse with its Allplex SARS-CoV-2/FluA/FluB/RSV Assay, a testing kit capable of concurrently identifying COVID-19, influenza A and B, as well as respiratory syncytial virus (RSV).
Increasing Use of Next-Generation Sequencing in Genomics Study
The Vietnam life science tools market has witnessed remarkable advancements in the field of genomics, revolutionizing research, diagnostics, and personalized medicine. Genomics has gained significant momentum in Vietnam due to increasing availability of next generation sequencing (NGS). NGS enables high-throughput sequencing of DNA, providing researchers with unprecedented insights into genetic variations, disease mechanisms, and therapeutic targets. The adoption of NGS platforms in Vietnam has opened new avenues for genomic research and has allowed for the identification of genetic markers associated with diseases prevalent in the region. Moreover, the decreasing cost of genomic sequencing has made it more accessible to researchers and healthcare providers in Vietnam. This affordability has facilitated large-scale genomic studies, population-based research, and the integration of genomics into clinical practice. Genomic profiling of patients allows for personalized treatment strategies, targeted therapies, and better disease management.
For instance, in March 2023 Vietnam, Gene Solutions successfully created a multimodal liquid biopsy assay called SPOT-MAS (Screening for the Presence of Tumor by Methylation and Size). This innovative assay enables the detection of the five prevalent cancers namely liver, breast, colorectal, gastric, and lung cancer.
Technological Advancements
Technological advancements in the Vietnam Life Sciences Tools Market are reshaping the landscape of scientific research and development. One area of progress is the development of advanced imaging and microscopy tools that enable scientists to visualize and analyze biological samples with exceptional detail. This includes the use of confocal microscopy, super-resolution microscopy, and live-cell imaging techniques, which aid in unravelling complex biological processes at the cellular and molecular levels. Furthermore, there have been advancements in the field of flow cytometry, allowing for more precise and multiparametric analysis of cells and particles. The integration of robotics and automation systems in laboratories has enhanced efficiency and accuracy in sample handling, data collection, and analysis.
Additionally, the rise of bioinformatics tools and software has enabled the mining and interpretation of vast amounts of genomic and proteomic data, facilitating insights into disease mechanisms, drug discovery, and personalized medicine. The integration of automation and robotics into the life science tools market can enhance research capabilities and increase productivity.
During February 2023, FunBrain , a health tech startup headquartered in Vietnam, implemented AI models across over 100 hospitals. This deployment involved utilizing NVIDIA DGX SuperPOD and NVIDIA Clara to enhance the detection of abnormalities and expedite the diagnostic process.
Government Initiatives
The government aims to enhance the country's research capabilities and technological advancements, including in the field of life sciences. The goal is to promote research, development, and commercialization of biotechnology products and services. Various measures, such as tax incentives and funding support, are in place to encourage investment in the biotechnology sector. Government has established a Science and Technology development fund to provide financial support for research and development activities. This fund encourages collaboration between research institutions, universities, and enterprises in the field of life sciences and other scientific disciplines. Science and Technology enterprises development program aims to foster the development of science and technology enterprises, including those operating in the life science tools market. The government is providing support through funding, training, and other forms of assistance to encourage the growth and innovation of these enterprises.
The government has implemented various investment promotion policies to attract both domestic and foreign investment in the life science sector. These policies provide incentives such as tax breaks, land-use rights, and streamlined administrative procedures to encourage companies to establish operations in Vietnam.
In 2021, Vietnam initiated the establishment of the National Innovation Centre (NIC), valued at USD 32 million (740 billion VND). Situated in the Hoa Lac hi-tech park on the outskirts of Hanoi, the NIC spans an area of 35 hectares. Its primary objective is to foster the growth of start-ups and innovation by creating an ecosystem that promotes scientific and technological advancements. The NIC envisions promoting both local and international innovative enterprises, facilitating the establishment of laboratories and offices for prominent corporations, and serving as a hub for renowned experts and scientists.
Impact of COVID-19
The COVID-19 pandemic has had a significant impact on the life science tools market in Vietnam. As the country grappled with the challenges posed by the pandemic, there was a surge in demand for various life science tools and technologies to support research, testing, and diagnostics. One of the key effects of the pandemic was the increased focus on research and development related to vaccines, therapeutics, and diagnostic tools. Vietnam witnessed a significant rise in investments and collaborations aimed at developing indigenous solutions to combat the virus. This led to a surge in demand for life science tools such as PCR machines, nucleic acid extraction kits, and sequencing platforms.
Furthermore, the pandemic prompted the expansion and strengthening of healthcare infrastructure in Vietnam. The government and private sector organizations invested heavily in setting up new laboratories, testing facilities, and research centers. This expansion created a higher demand for a wide range of life science tools and equipment, including molecular biology reagents, cell culture systems, and laboratory consumables.
Key Players Landscape and Outlook
The life science tools market in Vietnam is characterized by the presence of several key players offering a diverse range of products and services and are playing a crucial role in driving innovation, research, and development in the country's life sciences industry. The outlook for the Vietnam life science tools market is positive, driven by factors such as increasing investments in research and development, government initiatives to boost the healthcare sector, and growing collaborations with international players.
In August 2021, Arcturus Therapeutics Holdings Inc., a startup based in the United States, has announced a partnership with Vinbiocare Biotechnology Joint Stock Company (Vinbiocare), a subsidiary of Vingroup Joint Stock Company. The collaboration aims to establish a production facility in Vietnam to manufacture Arcturus' experimental COVID-19 vaccines specifically for sale and use within Vietnam. According to the agreement, Vinbiocare will construct the manufacturing facility in Vietnam under the guidance of Arcturus. Additionally, Arcturus will grant Vinbiocare access to its exclusive technologies and processes required for producing the investigational COVID-19 vaccines.